• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Vascular Diseases

    Journal of Vascular Diseases

    JournalISSN 2813-2475eISSN 2813-2475

    年发文量

    研究主题

    论文(187)

    排序
    1Treatment and Outcomes of Clinical Bioprosthetic Valve Thrombosis after Surgical and Transcatheter Valve Replacement: A Narrative Review
    Sunil K. Ohri

    Clinically significant thrombosis of surgical and transcatheter biological valves is increasingly recognised, yet most reviews have concentrated on subclinical leaflet thrombosis after transcatheter aortic valve implantation. This narrative review examines treatment and outcomes after diagnosis of clinical bioprosthetic valve thrombosis in the aortic or mitral position, keeping asymptomatic hypoattenuated leaflet thickening separate. The evidence consists of 17 observational cohorts and case series, several of which overlap, include right-sided valves or use treatment response as part of the diagnosis; no randomised treatment trial has been reported. After anticoagulation, mainly with vitamin K antagonists, most studies reported haemodynamic improvement in most patients assessed, but endpoints and denominators varied; in one transcatheter registry, complete resolution was reported in 12 of 26 patients (46%), a figure that included two patients who were not anticoagulated. Recovery often took several months. Recurrence and bleeding estimates come mainly from one mixed-valve cohort that included right-sided prostheses: thrombosis recurred in 23% of initial responders, and major bleeding occurred in 12% of treated patients versus 2% of matched controls, an observational difference that cannot be attributed wholly to anticoagulation. Evidence for thrombolysis, redo surgery and transcatheter reintervention is limited to small series and case reports. The evidence supports confirming suspected thrombosis with transoesophageal echocardiography or four-dimensional computed tomography, starting a vitamin K antagonist in haemodynamically stable patients, referring unstable patients or those with persistent obstruction for a Heart Team decision, and individualising extended anticoagulation against bleeding risk. Direct oral anticoagulants are not established for clinical thrombosis, and the optimal duration of treatment is unknown.

    2026
    引用
    AI阅读
    加入学术空间
    2Artificial Intelligence in Stroke Imaging: Hype or Hope? from Basic Principles to Clinical Evidence
    Nicola Morelli,Marco Spallazzi,Eugenia Rota,Simone Gallerini,Davide Colombi

    Artificial intelligence (AI) is increasingly integrated into acute stroke imaging, offering new opportunities for automated image interpretation, diagnostic support, and workflow optimization. However, understanding its clinical value requires distinguishing the underlying computational methods from their diagnostic applications and demonstrated effects on patient care. This narrative educational review introduces the fundamental principles of machine learning, deep learning, and computer vision, with particular emphasis on convolutional neural networks and their applications in cerebrovascular imaging. Current evidence is examined across intracranial hemorrhage detection and volumetry, recognition of early ischemic changes, automated Alberta Stroke Program Early CT Score (ASPECTS) assessment, arterial occlusion detection, cerebral perfusion analysis, and ischemic lesion segmentation. Emerging applications in stroke etiology assessment are also discussed. Particular attention is given to persistent diagnostic challenges involving acute lacunar infarcts and cerebral small vessel disease, where conventional imaging limitations and insufficient external validation constrain current AI approaches. The review also examines generalizability, workflow integration, and regulatory considerations. AI can assist selected diagnostic tasks, but its clinical usefulness depends on external validation, appropriate implementation, and evidence of patient benefit.

    2026
    引用
    AI阅读
    加入学术空间
    3Endothelial Activation in Deep Vein Thrombosis and Chronic Venous Insufficiency: an Exploratory Pilot Study
    José Pesenti,Katherine Rivera,Gonzalo Martínez,Marcelo E. Andia

    Background: Deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and atherosclerosis have traditionally been regarded as distinct conditions, although they may share mechanisms involving inflammation and endothelial dysfunction. Objective: To explore the relationship between DVT, CVI, inflammatory biomarkers, and carotid plaque burden using machine learning. Methods: We included 10 patients with DVT (>1 year after diagnosis), 10 with CVI, and 10 age-, sex-, and cardiovascular risk factor- frequency-matched controls. Circulating endothelial cells (CEC), ICAM-1, CXCL7, and high-sensitivity C-reactive protein (hs-CRP) were measured. Participants underwent carotid magnetic resonance imaging, with plaques classified according to the American Heart Association (AHA) score. Kernel principal component analysis (kPCA) was followed by k-nearest neighbors (kNN) (k = 3). Results: Only ICAM-1 differed significantly between clinical groups (median [IQR]: controls, 0.41 [0.37–0.43]; DVT, 0.70 [0.61–0.79]; CVI, 0.64 [0.61–0.79] pg/mL; p < 0.001). kPCA followed by kNN identified three classes: Class 1 included 9 controls; Class 2 included 8 CVI participants and 1 control; and Class 3 included 10 DVT and 2 CVI. The prevalence of AHA plaque scores ≥3 was descriptively higher in Classes 2 and 3 than in Class 1 (77.8%, 83.3%, and 33.3%, respectively), although the overall difference did not reach statistical significance (p = 0.071). Conclusions: ICAM-1 was the only biomarker differing significantly between clinical groups. Exploratory kPCA and kNN analyses identified multidimensional patterns associated with DVT and CVI. Differences in the prevalence of AHA plaque scores ≥3 across kNN classes did not reach statistical significance. These findings are hypothesis-generating and require validation in larger cohorts.

    2026
    引用
    AI阅读
    加入学术空间
    4Association Between PM2.5 Exposure and Type 2 Diabetes Across the Cardiovascular–Kidney–Metabolic (CKM) Continuum (APEX-T2D): an Umbrella Review of Systematic Reviews and Meta-Analyses
    Yashendra Sethi,Nirja Kaka, Saurabh Singhal, Manvi Vasudev,Giuseppe Biondi-Zoccai,Anoop Misra

    Aims: Long-term exposure to fine particulate matter (PM2.5) is a near-universal and modifiable exposure. We synthesised the systematic review-level evidence linking PM2.5 to type 2 diabetes (T2D) and examined how far agreement between reviews reflects independent replication rather than repeated analysis of shared primary studies. Methods and Results: We searched PubMed, Embase, Scopus, Web of Science and Google Scholar to 10 May 2026 (PROSPERO CRD42025642487), appraised reviews with the JBI checklist, and graded certainty using GRADE separately for each outcome domain. Thirteen systematic reviews and meta-analyses were included, spanning more than 200 million cumulative participant observations. All seven reviews reporting incident T2D found a positive association; six clustered at hazard or relative risks of 1.10–1.16 per 10 µg/m3, with a dose–response gradient and comparable estimates in Asian and Western populations. Associations were also reported for prevalent T2D (OR 1.12–1.25), diabetes-related mortality (RR 1.08, 1.03–1.13) and fasting plasma glucose (+1.18%, 0.86–1.50); HOMA-IR was null. Positive associations persisted in populations with annual means near the WHO guideline value of 5 µg/m3. Certainty was low for incident T2D—the ceiling attainable for an non-randomisable observational exposure—and very low for secondary outcomes; heterogeneity exceeded 90%, and because the reviews draw on shared primary studies their agreement is not independent replication. Conclusions: Across the whole review-level literature, long-term PM2.5 exposure is consistently associated with a 10–16% higher risk of T2D per 10 µg/m3. Because exposure is near-universal, an association of this size at the individual level implies a substantial attributable burden, greatest in South Asia. PM2.5 belongs within cardiometabolic prevention and within the cardiovascular–kidney–metabolic continuum, although causality and reversibility remain untested.

    2026
    引用
    AI阅读
    加入学术空间
    5Predictive Value of the Triglyceride–Glucose Index for Major Adverse Cardiovascular Events in Patients with Premature Coronary Artery Disease
    Saadet Bülüç, Fatih Akın, Oğuzhan Çelik, Aytaç Pekmezci

    Background: Premature coronary artery disease (PCAD) represents a growing clinical concern. Although insulin resistance is central to atherogenesis and the triglyceride–glucose (TyG) index serves as a practical surrogate for insulin resistance, its specific prognostic capacity within younger patient cohorts remains poorly understood. This study sought to evaluate the prognostic value of the TyG index regarding major adverse cardiovascular events (MACE) and its correlation with angiographic disease severity in PCAD patients. Methods: Enrolling 382 consecutive patients presenting with acute coronary syndrome (ACS) undergoing primary or early invasive coronary angiography between July 2020 and March 2023, this retrospective study evaluated subjects stratified into premature CAD (males ≤ 45, females ≤ 55 years; n = 138) and late-onset CAD (n = 244) cohorts. Lesion complexity was evaluated via the Gensini score. Primary prognosis was evaluated via cumulative MACE during a mean follow-up of 40.7 months. Results: Baseline values for the TyG index did not exhibit significant variance between early-onset and late-onset cohorts (9.09 ± 0.71 vs. 9.06 ± 0.65, p = 0.716). Stratification by median TyG index in early-onset CAD showed expected metabolic clustering but no difference in Gensini scores (41.68 ± 25.90 vs. 44.12 ± 22.75, p = 0.321). In univariable logistic regression, baseline TyG index was not associated with MACE (OR = 1.10, 95% CI: 0.65–1.85, p = 0.732), whereas older age (OR = 1.06, 95% CI: 1.01–1.11, p = 0.017) and elevated baseline CRP levels (OR = 1.04, 95% CI: 1.01–1.08, p = 0.007) showed significant univariable associations with adverse clinical outcomes. Sensitivity analysis in non-diabetic patients (n = 275) confirmed no significant association between TyG index and MACE (OR = 0.721, 95% CI: 0.327–1.591, p = 0.418). Conclusion: In this study, the admission TyG index did not show a statistically significant relationship with coronary anatomical severity or long-term clinical outcomes in premature CAD. Risk assessment in acute coronary patients should continue to prioritize established clinical, acute inflammatory, and angiographic parameters.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 187 篇论文

    高被引作者

    作者引用发文
    Regis Radermecker231
    Divine C Nwafor191
    Mark A Colantonio191
    Brandon Lucke-Wold199
    Elochukwu Ibekwe191
    Jonathan Kopel141
    Sanjay Awasthi141
    Mostafa Abohelwa141
    Yogesh C Awasthi141
    Scott Shurmur141

    高产作者

    作者引用发文
    Brandon Lucke-Wold199
    Raffaele Serra66
    Michael Karsy04
    Davide Costa53
    Denise Baloi03
    Umberto Bracale53
    Hans Henkes13
    Danyas Sarathy03
    Ferdinando Paternostro13
    Nicola Ielapi43

    相关期刊

    Angiology
    American journal of hypertension
    Cardiology
    Cardiovascular research
    Circulation
    Vascular health and risk management
    Therapeutic advances in cardiovascular disease
    Pulse (Basel, Switzerland)
    Current Vascular Pharmacology
    ARYA Atherosclerosis